Technology transfer of pharmaceutical products

15 February 2023 09:00-17:00, Reading, United Kingdom


Introduction
Technology Transfer (TT) is a critical task in the increasingly global and collaborative pharmaceutical industry. To succeed in this interconnected world, companies must seamlessly transfer active pharmaceutical ingredients, finished dosage forms and analytical methods between in-house and third-party development and manufacturing sites around the world.Such transfers often involve multiple processes shaped by different national and organisational cultures, potentially creating scope for damaging delays that may impact operations, procedures, facilities, methods and a host of other related areas.

TT often has regulatory implications too.Successful completion of this course will equip individuals with an understanding of how these and other factors may affect the TT process, including the importance of control strategies to enable successful transfers to be executed to meet predefined criteria. The course features presentations, exercises and case studies, including content from RSSL’s own analytical lab experiences, to facilitate participant learning.

TT often has regulatory implications too.Successful completion of this course will equip individuals with an understanding of how these and other factors may affect the TT process, including the importance of control strategies to enable successful transfers to be executed to meet predefined criteria. The course features presentations, exercises and case studies, including content from RSSL’s own analytical lab experiences, to facilitate participant learning.
 
Venue
RSSL

RSSL, Reading Science Centre, Whiteknights Campus, Pepper Lane, Reading, RG6 6LA, United Kingdom

Contact information
RSSL Training
Reading Scientific Services Ltd
Reading Science Centre
Whiteknights Campus
Reading
Berkshire
RG6 6LA
+441189184076
Contact us by email

Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*